Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
And you would be dead because you have no clue how long it takes to get into a clinical trial, how low the odds are of you meeting the inclusion/exclusion criteria, and how much competition there is to get into a tiny trial.
And yes, I've done it and I had time, a lot of luck, some contacts, location advantage, and my trial was much bigger than any DCVax combo trial
I guess if you own shares of this garbage, you need that pie in the sky optimism.
You should buy some more endless cheapies. And in 10 years you will be even more broke. At least on paper as no idiot long will ever sells this turd. It's the long mantra. DON'T MAKE MONEY!
LP is in the catbird seat. She's swindled you morons through not one but two built out CDMOs she sold for herself.
The trial sucked so bad they had to redesign it after the fact (totaled opposed to the FDA's adequate, well defined trial design requirement) and even then had the mOS drop after they removed the patients who didn't even receive DCVax.
Now most longs have already moved on from the doomed P3 by tying their hopes to a tiny combo mish mash trial of 3 arms with for different levels of glioma which is not powered to show efficacy.
4 YEARS after data lock and they still haven't begun a submission to the FDA because they know the data and trial are a non-starter. So they kicked the can down the road with the MHRA submission to lessen the impact of the futility.
Not to mention it's in direct conflict with Direct, which has zero effect on the tumor. This quote will come back to haunt her after L is denied by MHRA and they have to reboot Direct for suckers to keep the company afloat til she sells Advent.
High Five!
What, she sold Advent already?
You've been suggesting wrong BS for 10 years now. What was the SP when you first starting shilling for the company?
That's $100 on a million shares. If this is going to $100/share like all the shills say, why care about .0001? You could always pay the ask for this dumpster fire if you really want the shares.
Gee, you should read his tweets. He's been as wrong as you.
And you've thought this stock was a great investment since 2014. So for 10 years, you've been incorrect.
Or you could simply look at a company who worked with the FDA on their external trial design for their GBM P3 in 2020.
Trial also wasn't powered to prove efficacy for rGBM. Not a chance anyone approves it for rGBM let alone GBM. Well maybe Switzerland.
Nobody here invested in this scam to fight cancer. They did it to make money. I take it you don't own an SP500 index fund? Here's a hint. It contains shares of big tobacco. So you are supporting cancer.
You should look up the word disciple. It has multiple meanings. Just as douche is not just a feminine hygiene product. Can you figure out where I'm going with this?
Or maybe flipper is baking a few more loaves of bread so everyone can follow the breadcrumbs for answers. He's been soooo accurate.
And yet many of the contributors on the NWBO Jama article recommend Optune and prescribe it. Go figure.
The only trial (the P3) NWBO has run that matters:
Yes the famous cherry picked patient endpoint the FDA is looking for.
So I guess your argument is that NWBO doesn't know how to design trials. Agreed. It's hard to design a trial that proves one water is better than another.
That's as relevant to this board as Walmart putting aspirin on sale.
What better explains it:
DSMB futility recommendation at IA.
RAs halt trial enrollment but allow those in the pipeline to continue because DCVax is essentially a placebo with low side effects.
If there was a positive or even non-negative reason, the company would have cleared it up in a PR. Lord knows they've PRed enough about wolf packs and nefarious actors. How about PRing to clear up your shitty trial and all the red flags?
You can't shake the scent of the POS you shill for daily on this board.
148 weeks.
Paid shills are happy with LPs multiple CDMO buildouts..
Yeah there's no desire for the majority of those 69 who have never been published before to notch their first contributing credit regardless of the validity of the data or all the questions around the trial design.
And there's those who have actually been published before, 5 in the Optune trial data release Jama article. Is that a conflict or only if one questions the data like even one of the most respected experts in GBM (Stupp), who NWBO paid as a consultant, did?
BP would’ve pulled the plug when the DMSC gave the futility rec.
It was so great they haven’t submitted a BLA 2 years after publication. 4 years after data lock.
You should buy more. Or wait a couple weeks for the .20s.
Well Liau ran a trial showing L showed no benefit on established tumors. Then followed that up with the P3 showing it does nothing for anybody.
Yeah just like Polaroid.
That's because they announced they had finished all prerequisites for MAA submission on the 8-29-2024. And then they followed it with Liau joining the board where the SP peaked and then they followed with fluff PRs up to the actual MAA submission and none could keep the SP afloat because the only other binary event to anticipate is MAA decision which simple math showed was 300+ days away.
He said he's long many times. Maybe quit worrying about what your next bullshit post will be and start actually paying attention the the few non-shills that have said they are invested yet have expressed issues with the company.
Such bullshit conspiracy theories. Maybe stop listening to flipper.
DCVax JAMA authors also authors of Jama's Optune trial article
Steven Brem
Steven Toms
Karen Fink
David Tran
So are these guys in on it? Whose side are they on? Can you please trash them like all other doctors who aren't involved with DCVax and don't think DCVax does shit?
And that's only JAMA publications. If DCVax worked, the two treatments could be used in conjunction as they are two totally different pathways but it's irrelevant because in their own study, DCVax is worse than placebo.
Coming soon: "For sale, built out CDMO in Sawston"
NWBO's record keeping failures
Guess that's how we relate your link to this company.
Flaskworks news would be when they start a comparability study.
10 years happens after 18 weeks. And a more likely time period for approval.
Nobody except delusional longs and shills on this board think this is "at the point of getting an approval decision". Even at the snowballs chance in hell of approval, there would be no reimbursement, just like there isn't for Optune. Companies at the point of getting an approval generally go up, not hit 52 week lows. They usually aren't toiling away on the OTC either. And those companies are at the point of getting approval from the FDA, not the MHRA, and there is no submission for solid cancers or combos with DCVax or anything else on your Fantasy Island.
Don't compare me to him. I've been correct the majority of the time. Being negative about a scammy company that hasn't produced anything since it went public in 2001 IS NOT the same as pumping a company that has lost shareholders 99.9% of stock price since 2001.